Eli Lilly | Nettoeinkommen



Net Income Veränderung Datum
AbbVie USD 938M 348M 2025-06
Abbott USD 1.78B 454M 2025-06
ALKERMES USD 87.1M 64.63M 2025-06
Amgen USD 1.43B 298M 2025-06
AstraZeneca USD 2.45B 466M 2025-06
Baxter International USD 91M 35M 2025-06
Biogen USD 634.8M 394.3M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Drreddys Laboratories INR 14.18B 45M 2025-06
Eli Lilly USD 5.66B 2.9B 2025-06
Gilead Sciences USD 1.96B 645M 2025-06
GlaxoSmithKline GBP 1.44B 181M 2025-06
Glaxosmithkline GBP 1.44B 1.03B 2025-06
J&J USD 5.54B 5.46B 2025-06
Medtronic USD 1.04B 17M 2025-07
Merck USD 4.43B 652M 2025-06
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
Novartis USD 4.02B 418M 2025-06
Novartis USD 4.04B 1.22B 2025-06
Novo Nordisk 26.5B 2.53B 2025-06
Perrigo USD -8400000 2M 2025-06
Pfizer USD 2.91B 58M 2025-06
Prestige Brands USD 61.78M 11.65M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 3.94B 2.07B 2025-06
Sanofi EUR 3.94B 3.44B 2025-06
United Therapeutics USD 309.5M 12.7M 2025-06
Zoetis USD 718M 87M 2025-06


Eli Lilly Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.